Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00908999 · ClinicalTrials.gov registry record
Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 60
- Enrollment target
NCT00908999 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 60 participants.
The verdict
NCT00908999 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This is a three year fMRI study conducted at the University of Wisconsin (UW) Hospital and the William. S. Middleton VA Hospital. This study is guided by the hypothesis that reduced fMRI activity and connectivity cortical midline structures (i.e., medial frontal and ventral posterior cingulate cortex) are physiologic abnormalities that relate strongly to the compromised insight into cognitive deficits, or anosognosia, shown by a subset of individuals with amnestic MCI (aMCI) and AD. Further, the investigators hypothesize that these regional changes in fMRI activity are predictive of faster progression from aMCI to AD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00908999
The ClinicalTrials.gov registry entry for NCT00908999 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00908999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00908999 about?
NCT00908999 is a clinical study titled "Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)". This is a three year fMRI study conducted at the University of Wisconsin (UW) Hospital and the William. S. Middleton VA Hospital. This study is guided by the hypothesis that reduced fMRI activity and connectivity cortical midline structures (i.e., medial frontal and ventral posterior cingulate corte...
What is the current status of trial NCT00908999?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2008-04. Estimated completion is 2011-09.
Who is sponsoring clinical trial NCT00908999?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.